NZ510776A - Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin - Google Patents

Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin

Info

Publication number
NZ510776A
NZ510776A NZ510776A NZ51077699A NZ510776A NZ 510776 A NZ510776 A NZ 510776A NZ 510776 A NZ510776 A NZ 510776A NZ 51077699 A NZ51077699 A NZ 51077699A NZ 510776 A NZ510776 A NZ 510776A
Authority
NZ
New Zealand
Prior art keywords
cyclodextrin
solution
nasal spray
sex hormones
preparing
Prior art date
Application number
NZ510776A
Inventor
Gilles Fonknechten
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NZ510776A publication Critical patent/NZ510776A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Nanotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Process for the preparation of a nasal spray solution comprising one or more sex hormones and cyclodextrin, wherein (a) the cyclodextrin is dissolved in purified water at a concentration of 100 - 1000 mg/ml; (b) the hormone(s) is/are added and the mixture heated to 40 - 90 °C; and (c) purified water is added to give the final, desired concentration of hormone(s), this addition taking place either immediately or after lyophilisation of the preceding solution.
NZ510776A 1998-10-14 1999-10-13 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin NZ510776A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9812836A FR2784584B1 (en) 1998-10-14 1998-10-14 PROCESS FOR THE PREPARATION OF A NASAL SPRAY SOLUTION CONTAINING ONE OR MORE SEXUAL HORMONES AND A CYCLODEXTRIN
PCT/FR1999/002480 WO2000021503A1 (en) 1998-10-14 1999-10-13 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin

Publications (1)

Publication Number Publication Date
NZ510776A true NZ510776A (en) 2002-10-25

Family

ID=9531516

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510776A NZ510776A (en) 1998-10-14 1999-10-13 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin

Country Status (21)

Country Link
EP (1) EP1121100B1 (en)
JP (1) JP3911125B2 (en)
KR (1) KR100462441B1 (en)
CN (1) CN1323198A (en)
AT (1) ATE237310T1 (en)
AU (1) AU756441B2 (en)
BR (1) BR9914532A (en)
CA (1) CA2346567C (en)
DE (1) DE69907005T2 (en)
DK (1) DK1121100T3 (en)
EA (1) EA003069B1 (en)
ES (1) ES2197672T3 (en)
FR (1) FR2784584B1 (en)
HK (1) HK1040201A1 (en)
HU (1) HUP0103968A3 (en)
NO (1) NO20011673L (en)
NZ (1) NZ510776A (en)
PL (1) PL347322A1 (en)
PT (1) PT1121100E (en)
WO (1) WO2000021503A1 (en)
ZA (1) ZA200102961B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827516B1 (en) * 2001-07-19 2003-09-19 Servier Lab PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION OF ESTRADIOL AND NORETHISTERONE
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
GB2482868A (en) 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration
CA2851424A1 (en) * 2011-10-07 2013-04-11 Florida State University Research Foundation Prophylactic and post-acute use of progesterone to better outcomes associated with concussion
ES2575676T3 (en) 2012-01-20 2016-06-30 Aratana Therapeutics Nv Eye drops composition
RU2753511C2 (en) * 2017-05-31 2021-08-17 Аратана Терапьютикс, Инк. Composition of eye drops

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801670A (en) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan PHARMACEUTICAL PREPARATION.
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
DE4207922A1 (en) * 1992-03-13 1993-09-23 Pharmatech Gmbh New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water
BE1007402A5 (en) * 1993-03-26 1995-06-06 Adir NASAL PHARMACEUTICAL PREPARATIONS WITH progestagen SUBSTANCE.

Also Published As

Publication number Publication date
KR100462441B1 (en) 2004-12-17
ES2197672T3 (en) 2004-01-01
PL347322A1 (en) 2002-03-25
HUP0103968A3 (en) 2002-06-28
NO20011673D0 (en) 2001-04-03
KR20010073214A (en) 2001-07-31
ATE237310T1 (en) 2003-05-15
FR2784584B1 (en) 2002-09-20
DE69907005D1 (en) 2003-05-22
EA200100316A1 (en) 2002-02-28
CN1323198A (en) 2001-11-21
PT1121100E (en) 2003-07-31
HUP0103968A2 (en) 2002-04-29
WO2000021503A1 (en) 2000-04-20
DE69907005T2 (en) 2004-03-18
CA2346567C (en) 2005-06-14
JP3911125B2 (en) 2007-05-09
JP2002527374A (en) 2002-08-27
CA2346567A1 (en) 2000-04-20
FR2784584A1 (en) 2000-04-21
NO20011673L (en) 2001-04-03
AU756441B2 (en) 2003-01-16
BR9914532A (en) 2001-11-06
ZA200102961B (en) 2001-11-20
EA003069B1 (en) 2002-12-26
AU6096799A (en) 2000-05-01
DK1121100T3 (en) 2003-07-21
EP1121100B1 (en) 2003-04-16
EP1121100A1 (en) 2001-08-08
HK1040201A1 (en) 2002-05-31

Similar Documents

Publication Publication Date Title
BR9908273A (en) Formulations
ATE256460T1 (en) PREPARATION FOR NASAL ADMINISTRATION CONTAINING VIBRIO CHOLERA ZONULA OCCLUDENS TOXIN AS ABSORPTION MEDIATOR
MY129581A (en) New 3-aryl propionic acid derivatives and analogs
ES2117642T3 (en) PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLES AND N-ETILEN GLYCOLS.
DK1098643T3 (en) Phenylacetylglutamine, phenylacetylisoglutamine and / or phenylacetate for the treatment of neoplastic diseases
JPS6470415A (en) Skin permeable remedy system
DE60028152D1 (en) Solid, stable and concentrated biologically digestible complex of orthosilicic acid and process for its preparation
NZ510776A (en) Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
DE69924004D1 (en) ADMINISTRATION SYSTEM FOR WATER-INSOLUBLE MEDICINES
ES2001875A6 (en) Amino acid derivatives, process for their preparation and use.
IL132676A0 (en) Improvements in or relating to long-acting antimicrobials
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
UA13377A (en) Method for preparing antiviral composition
DE69131517D1 (en) Use of prostaglandin E1 to treat male erectile impotence
CO5021217A1 (en) STABLE COMPOSITIONS OF MITOXANTRONE, PROCEDURE TO PREPARE THEM; USE OF SUCH COMPOSITIONS AND MEDICATIONS THAT INCLUDE SUCH SOLUTIONS FOR THE TREATMENT OF CANCER DISEASES
IT1298268B1 (en) PROCEDURE FOR THE PREPARATION OF THE (S) -2-BROMO-3-PHENYL-PROPIONIC ACID
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
DE69102143T2 (en) MEDICINAL PRODUCTS CONTAINING SPIRAMYCIN AND METHOD FOR THE PRODUCTION THEREOF.
WO2000032224A3 (en) Calcitonin for the modulation of sperm function
DE3666588D1 (en) Spiroûbenzofuran-2(3h), 1'cycloheptane¨s, a process and intermediates for their preparation and their use as medicaments
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
DK0865422T3 (en) Use of amino alcohol derivatives as drugs, novel derivatives and process for their preparation
JPH0376291B2 (en)
MX9703839A (en) Lubeluzole intravenous solutions.
EP0705606A1 (en) Use of 5-Thia-1,4-diazabicyclo [4.2.0] octane-3,8-dioxo compounds in antitumor therapy

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: LES LABORATOIRES SERVIER, FR

Free format text: OLD OWNER(S): ADIR ET COMPAGNIE

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)